Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures
Avisek Majumder
Cancers (2023) Vol. 16, Iss. 1, pp. 39-39
Open Access | Times Cited: 13

Showing 13 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations
Philipp Blüm, Sabine Käyser
Cancers (2024) Vol. 16, Iss. 8, pp. 1599-1599
Open Access | Times Cited: 9
How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer
Avisek Majumder, Shabana Bano
Biomolecules (2024) Vol. 14, Iss. 6, pp. 633-633
Open Access | Times Cited: 5
Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation
Hadeer Mohamed Ahmed, Said S. Moselhy, Magda I. Mohamad, et al.
Annals of Hematology (2025)
Open Access
Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy
Clement Chung, Duc Hoang Doan
European Journal Of Haematology (2025)
Closed Access
A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy
Angel A Justiz-Vaillant, Bijay Raj Pandit, Chandrashekhar Unakal, et al.
Antibodies (2025) Vol. 14, Iss. 2, pp. 35-35
Open Access
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells
Kohei Mitsuno, Masaya Suematsu, Yuki Naito, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Deciphering the Potentials of Cardamom in Cancer Prevention and Therapy: From Kitchen to Clinic
Shabana Bano, Avisek Majumder, Ayush Srivastava, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1166-1166
Open Access | Times Cited: 3
Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma using computational approaches
Prasanna Srinivasan Ramalingam, T. Premkumar, Vino Sundararajan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Advancement in “Off-the-Shelf” CAR T-Cell Therapy for Cancer Immunotherapy
Mohsen Sheykhhassan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 33-92
Closed Access | Times Cited: 1
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process
Avisek Majumder, Shabana Bano, Kasturi Bala Nayak
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1387-1387
Open Access
Claudine 18.2 : nouvelle cible thérapeutique dans les cancers digestifs
Laure Blondet, Baptiste Cervantes, Florence Renaud, et al.
Bulletin du Cancer (2024) Vol. 111, Iss. 12, pp. 1133-1141
Open Access
CAR-T Cell Therapy: The Limitation and Solution
S Y Wang
Highlights in Science Engineering and Technology (2024) Vol. 102, pp. 444-450
Closed Access
Page 1

Scroll to top